Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company?
- Tuesday, January 18, 2022, 7:21
- Market
- Add a comment
We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to Pfizer stock (NYSE: PFE), given its better growth prospects and comparatively lower valuation of 3.0x trailing revenues, compared to 4.7x for Pfizer…
About the Author
admin123 has written 23544 stories on this site.
